Role of prefrontal cortical calcium independent phospholipase A2 in antidepressant-like effect of maprotiline

International Journal of Neuropsychopharmacology

Volumn 15, Issue 8, 2012, Pages 1087-1098

  Lee, Lynette Hui Wen ^a   Tan, Chay Hoon ^a   Shui, Guanghou ^a   Wenk, Markus R ^a   Ong, Wei Yi ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antidepressants; calcium independent phospholipase A2; docosahexaenoic acid; lipidomics; maprotiline; noradrenaline; norepinephrine; prefrontal cortex

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; MAPROTILINE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; FORCED SWIMMING TEST; IMMOBILIZATION; LIPIDOMICS; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CALCIUM; CELL DEATH; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FREEZING REACTION, CATALEPTIC; IN SITU NICK-END LABELING; INDOLES; LIPID METABOLISM; MALE; MAPROTILINE; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT; PREFRONTAL CORTEX; SWIMMING;

EID: 84864536724     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001234     Document Type: Article

References (51)

1. Adibhatla RM, Hatcher JF, Dempsey RJ (2006). Lipids and lipidomics in brain injury and diseases. AAPS Journal 8, E314-E321.
2. Balsinde J, Balboa MA, Dennis EA (1997). Antisense inhibition of group VI Ca2+-independent phospholipase a2 blocks phospholipid fatty acid remodeling in murine p388D1 macrophages. Journal of Biological Chemistry 272, 29317-29321.
3. Basselin M, Rosa AO, Ramadan E, Cheon Y, et al. (2010). Imaging decreased brain docosahexaenoic acid metabolism and signaling in iPLA2{beta} (VIA)-deficient mice. Journal of Lipid Research 51, 3166-3173.
4. Bazan NG (2009). Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin d1 signaling in photoreceptor cell survival and brain protection. Prostaglandins, Leukotrienes and Essential Fatty Acids 81, 205-211.
5. Bligh EG, Dyer WJ (1959). A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 37, 911-917.
6. Botteron KN, Raichle ME, Drevets WC, Heath AC, et al. (2002). Volumetric reduction in left subgenual prefrontal cortex in early onset depression. Biological Psychiatry 51, 342-344.
7. Cansev M, Wurtman RJ (2007). Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 148, 421-431.
8. Carrie I, Clement M, de Javel D, Frances H, et al. (2000). Specific phospholipid fatty acid composition of brain regions in mice. Effects of n-3 polyunsaturated fatty acid deficiency and phospholipid supplementation. Journal of Lipid Research 41, 465-472.
9. Conklin SM, Manuck SB, Yao JK, Flory JD, et al. (2007). High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosomatic Medicine 69, 932-934.
10. Cryan JF, Lucki I (2000). Antidepressant-like biobehavioral effects mediated by 5-hydroxytryptamine2C receptors. Neuropharmacology 295, 1120-1126.
11. Cryan JF, Markou A, Lucki I (2002). Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 23, 238-245.
12. Cryan JF, Valentino RJ, Lucki I (2005). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience & Biobehavioral Reviews 29, 547-589.
13. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K (2002). Depression: perspectives from affective neuroscience. Annual Review of Psychology 53, 545-574.
14. Detke MJ, Rickels M, Lucki I (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 121, 66-72.
15. Drevets WC (1998). Functional neuroimaging studies of depression: the anatomy of melancholia. Annual Review of Medicine 49, 341-361.
16. Drevets WC (2000). Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Progress in Brain Research 126, 413-431.
17. Drevets WC, Bogers W, Raichle ME (2002). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology 12, 527-544.
18. Farooqui AA, Horrocks LA (2001). Plasmalogens, phospholipase a2, and docosahexaenoic acid turnover in brain tissue. Journal of Molecular Neuroscience 16, 263-272; discussion 279-284.
19. Fei W, Shui G, Gaeta B, Du X, et al. (2008). Fld1p, a functional homologue of human seipin, regulates the size of lipid droplets in yeast. Journal of Cell Biology 180, 473-482.
20. Fisar Z (2005). Interactions between tricyclic antidepressants and phospholipid bilayer membranes. General Physiology and Biophysics 24, 161-180.
21. Fujita S, Ikegaya Y, Nishikawa M, Nishiyama N, et al. (2001). Docosahexaenoic acid improves long-term potentiation attenuated by phospholipase a(2) inhibitor in rat hippocampal slices. British Journal of Pharmacology 132, 1417-1422.
22. Green JT, Orr SK, Bazinet RP (2008). The emerging role of group VI calcium-independent phospholipase a2 in releasing docosahexaenoic acid from brain phospholipids. Journal of Lipid Research 49, 939-944.
23. Hulbert AJ, Turner N, Storlien LH, Else PL (2005). Dietary fats and membrane function: implications for metabolism and disease. Biological Reviews of the Cambridge Philosophical Society 80, 155-169.
24. Kiecolt-Glaser JK, Belury MA, Porter K, Beversdorf DQ, et al. (2007). Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults. Psychosomatic Medicine 69, 217-224.
25. Kimbrell TA, Ketter TA, George MS, Little JT, et al. (2002). Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biological Psychiatry 51, 237-252.
26. Lee LH, Shui G, Farooqui AA, Wenk MR, et al. (2009). Lipidomic analyses of the mouse brain after antidepressant treatment: evidence for endogenous release of long-chain fatty acids? International Journal of Neuropsychopharmacology 12, 953-964.
27. Lee LH, Tan CH, Lo YL, Farooqui AA, et al. (2011). Brain lipid changes after repetitive transcranial magnetic stimulation: potential links to therapeutic effects? Metabolomics. Published online: 12 February 2011. doi :10.1007/s11306-011-0285-4.
28. Logan AC (2004). Omega-3 fatty acids and major depression: a primer for the mental health professional. Lipids in Health and Disease 3, 25.
29. Maes M, Christophe A, Delanghe J, Altamura C, et al. (1999). Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Research 85, 275-291.
30. Maes M, Smith R, Christophe A, Cosyns P, et al. (1996). Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased c20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. Journal of Affective Disorders 38, 35-46.
31. McNamara RK, Jandacek R, Rider T, Tso P, et al. (2009). Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims. Prostaglandins, Leukotrienes and Essential Fatty Acids 80, 19-26.
32. Mischoulon D, Fava M (2000). Docosahexanoic acid and omega-3 fatty acids in depression. Psychiatric Clinics of North America 23, 785-794.
33. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG (2004). Neuroprotectin d1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proceedings of the National Academy of Sciences USA 101, 8491-8496.
34. Ong WY, Yeo JF, Ling SF, Farooqui AA (2005). Distribution of calcium-independent phospholipase A2 (iPLA 2) in monkey brain. Journal of Neurocytology 34, 447-458.
35. Ongur D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences USA 95, 13290-13295.
36. Parra A, Martos A, Monleon S, Carmen Arenas M, et al. (2000). Effects of acute and chronic maprotiline administration on inhibitory avoidance in male mice. Behavioural Brain Research 109, 1-7.
37. Paxinos G, Watson C (2001). The Mouse Brain in Stereotaxic Coordinates. New York: Elsevier.
38. Peet M, Murphy B, Shay J, Horrobin D (1998). Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biological Psychiatry 43, 315-319.
39. Porsolt RD, Bertin A, Jalfre M (1977). Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Therapie 229, 327-336.
40. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45, 1085-1098.
41. Rao JS, Ertley RN, DeMar Jr. JC, Rapoport SI, et al. (2007a). Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Molecular Psychiatry 12, 151-157.
42. Rao JS, Ertley RN, Lee HJ, DeMar Jr. JC, et al. (2007b). n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Molecular Psychiatry 12, 36-46.
43. Sakamoto T, Cansev M, Wurtman RJ (2007). Oral supplementation with docosahexaenoic acid and uridine-5k-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Research 1182, 50-59.
44. Schutter DJ (2009). Antidepressant efficacy of highfrequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychological Medicine 39, 65-75.
45. Shui G, Bendt AK, Pethe K, Dick T, et al. (2007). Sensitive profiling of chemically diverse bioactive lipids. Journal of Lipid Research 48, 1976-1984.
46. Strokin M, Sergeeva M, Reiser G (2003). Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. British Journal of Pharmacology 139, 1014-1022.
47. Strokin M, Sergeeva M, Reiser G (2007). Prostaglandin synthesis in rat brain astrocytes is under the control of the n-3 docosahexaenoic acid, released by group VIB calciumindependent phospholipase A2. Journal of Neurochemistry 102, 1771-1782.
48. Su KP, Huang SY, Chiu TH, Huang KC, et al. (2008). Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychiatry 69, 644-651.
49. Tan CH, He X, Yang J, Ong WY (2006). Changes in AMPA subunit expression in the mouse brain after chronic treatment with the antidepressant maprotiline: a link between noradrenergic and glutamatergic function? Experimental Brain Research 170, 448-456.
50. Wenk MR (2005). The emerging field of lipidomics. Nature Reviews Drug Discovery 4, 594-610.
51. Wurtman RJ, Cansev M, Ulus IH (2009). Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides. Journal of Nutrition, Health and Aging 13, 189-197.